STADA: CapVest Completes Majority Acquisition Of Global Pharmaceuticals Company - Pulse 2.0
CapVest→STADA Arzneimittel
Apr 1, 2026
Eris Lifesciences has completed the acquisition of Velbiom Probiotics, a pharmacy business in India. Velbiom Probiotics develops and supplies probiotic products for healthcare customers, supporting gut health and wellness needs. Eris Lifesciences acquisitions expand its pharmacy and healthcare M&A footprint by adding probiotic capabilities to its existing product portfolio. The Velbiom Probiotics acquisition is an add on acquisition within healthcare M&A, with deal size undisclosed and the transaction marked as closed.
CapVest→STADA Arzneimittel
Apr 1, 2026
Lilly→Centessa Pharmaceuticals
Mar 31, 2026
Jimini Health
Mar 31, 2026
Biogen→Apellis Pharmaceuticals
Mar 31, 2026
Biogen→Apellis Pharmaceuticals
Mar 31, 2026